David Larsen
Stock Analyst at BTIG
(2.10)
# 2,953
Out of 4,870 analysts
74
Total ratings
34.48%
Success rate
-1.27%
Average return
Main Sectors:
Stocks Rated by David Larsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DOCS Doximity | Upgrades: Buy | $80 | $57.98 | +37.98% | 2 | Jun 2, 2025 | |
| PGNY Progyny | Upgrades: Buy | $28 | $20.79 | +34.68% | 4 | Mar 31, 2025 | |
| HIMS Hims & Hers Health | Initiates: Buy | $35 | $41.98 | -16.63% | 1 | Jan 7, 2025 | |
| HQY HealthEquity | Maintains: Buy | $110 → $130 | $101.21 | +28.45% | 4 | Nov 14, 2024 | |
| CCSI Consensus Cloud Solutions | Maintains: Buy | $30 → $31 | $22.78 | +36.08% | 3 | Nov 11, 2024 | |
| IQV IQVIA Holdings | Maintains: Buy | $290 → $260 | $155.17 | +67.56% | 2 | Nov 1, 2024 | |
| SLP Simulations Plus | Maintains: Buy | $60 → $50 | $17.07 | +192.91% | 2 | Oct 24, 2024 | |
| BTSG BrightSpring Health Services | Maintains: Buy | $15 → $20 | $22.77 | -12.17% | 2 | Oct 3, 2024 | |
| ASTH Astrana Health | Maintains: Buy | $60 → $70 | $25.07 | +179.22% | 1 | Oct 3, 2024 | |
| DH Definitive Healthcare | Initiates: Buy | $7 | $3.97 | +76.32% | 1 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $240 | $280.30 | -14.38% | 1 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $7 | $1.69 | +314.20% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $14 | $14.30 | -2.10% | 3 | Apr 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $6.17 | - | 2 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $28.37 | - | 7 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $55 → $45 | $10.50 | +328.57% | 4 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $21 | $3.74 | +461.50% | 3 | Sep 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $2.15 | - | 1 | Jun 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $21.61 | +61.96% | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $7.89 | - | 3 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $95 | $6.56 | +1,348.17% | 2 | Oct 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $6.73 | - | 1 | Jan 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $163.99 | - | 6 | Nov 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $170 → $160 | $721.83 | -77.83% | 2 | May 29, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $75 → $70 | $11.35 | +516.74% | 3 | May 23, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $71.89 | - | 5 | Apr 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $85 | $66.81 | +27.23% | 3 | Feb 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $34 → $23 | $7.28 | +215.93% | 1 | Nov 2, 2017 |
Doximity
Jun 2, 2025
Upgrades: Buy
Price Target: $80
Current: $57.98
Upside: +37.98%
Progyny
Mar 31, 2025
Upgrades: Buy
Price Target: $28
Current: $20.79
Upside: +34.68%
Hims & Hers Health
Jan 7, 2025
Initiates: Buy
Price Target: $35
Current: $41.98
Upside: -16.63%
HealthEquity
Nov 14, 2024
Maintains: Buy
Price Target: $110 → $130
Current: $101.21
Upside: +28.45%
Consensus Cloud Solutions
Nov 11, 2024
Maintains: Buy
Price Target: $30 → $31
Current: $22.78
Upside: +36.08%
IQVIA Holdings
Nov 1, 2024
Maintains: Buy
Price Target: $290 → $260
Current: $155.17
Upside: +67.56%
Simulations Plus
Oct 24, 2024
Maintains: Buy
Price Target: $60 → $50
Current: $17.07
Upside: +192.91%
BrightSpring Health Services
Oct 3, 2024
Maintains: Buy
Price Target: $15 → $20
Current: $22.77
Upside: -12.17%
Astrana Health
Oct 3, 2024
Maintains: Buy
Price Target: $60 → $70
Current: $25.07
Upside: +179.22%
Definitive Healthcare
Sep 17, 2024
Initiates: Buy
Price Target: $7
Current: $3.97
Upside: +76.32%
Jul 9, 2024
Initiates: Buy
Price Target: $240
Current: $280.30
Upside: -14.38%
May 9, 2024
Maintains: Buy
Price Target: $11 → $7
Current: $1.69
Upside: +314.20%
Apr 23, 2024
Maintains: Buy
Price Target: $13 → $14
Current: $14.30
Upside: -2.10%
Apr 1, 2024
Downgrades: Neutral
Price Target: n/a
Current: $6.17
Upside: -
Nov 3, 2023
Downgrades: Neutral
Price Target: n/a
Current: $28.37
Upside: -
Oct 12, 2022
Maintains: Buy
Price Target: $55 → $45
Current: $10.50
Upside: +328.57%
Sep 26, 2022
Maintains: Buy
Price Target: $25 → $21
Current: $3.74
Upside: +461.50%
Jun 24, 2022
Initiates: Neutral
Price Target: n/a
Current: $2.15
Upside: -
Apr 28, 2022
Initiates: Buy
Price Target: $35
Current: $21.61
Upside: +61.96%
Nov 22, 2021
Downgrades: Neutral
Price Target: n/a
Current: $7.89
Upside: -
Oct 26, 2021
Maintains: Buy
Price Target: $80 → $95
Current: $6.56
Upside: +1,348.17%
Jan 7, 2021
Initiates: Neutral
Price Target: n/a
Current: $6.73
Upside: -
Nov 16, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $163.99
Upside: -
May 29, 2018
Maintains: Market Perform
Price Target: $170 → $160
Current: $721.83
Upside: -77.83%
May 23, 2018
Maintains: Market Perform
Price Target: $75 → $70
Current: $11.35
Upside: +516.74%
Apr 4, 2018
Upgrades: Outperform
Price Target: n/a
Current: $71.89
Upside: -
Feb 9, 2018
Maintains: Outperform
Price Target: $90 → $85
Current: $66.81
Upside: +27.23%
Nov 2, 2017
Maintains: Market Perform
Price Target: $34 → $23
Current: $7.28
Upside: +215.93%